Added to YB: 2024-03-03
Pitch date: 2024-03-03
MNKD:US [bullish]
MannKind Corporation
-28.04%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.
Market Cap
$991.7M
Pitch Price
$4.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.11
P/E
-37.00
EV/Sales
3.58
Sector
Biotechnology
Category
N/A
Show full summary:
MannKind Corporation MNKD:US
A summary for this pitch has not been created yet.
Read full article (0 min)